Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Gene Therapy

• Publication date

  2020-08-17

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1038/s41434-020-0182-4PMID 32807899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homologous recombination-based genome editing by clade F AAVs is inefficient in the absence of a targeted DNA break

  2019cited by this paper
• Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach.

  2019cited by this paper
• Onasemnogene Abeparvovec: First Global Approval

  2019cited by this paper
• Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer

  2019cited by this paper
• Two Decades of Molecular Therapy: The Journey Continues.

  2019cited by this paper
• Gene Therapy to Enhance Bone and Cartilage Repair in Orthopaedic Surgery.

  2018cited by this paper
• Gene Therapy for Vision Loss.

  2018cited by this paper
• In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair

  2018cited by this paper
• Cryopreservation of Human Adipose-Derived Stem Cells for Use in Ex Vivo Regional Gene Therapy for Bone Repair

  2018cited by this paper
• New Human Insulin Analog Approved.

  2018cited by this paper
• Clinical and Research Approaches to Treat Non-union Fracture

  2018cited by this paper
• Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2–Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow

  2017cited by this paper
• Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma

  2017cited by this paper
• Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?

  2017cited by this paper
• CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia

  2016cited by this paper
• Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.

  2016cited by this paper
• Adeno-Associated Virus 5 Transduces Adipose-Derived Stem Cells with Greater Efficacy Than Other Adeno-Associated Viral Serotypes

  2016cited by this paper
• Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.

  2016cited by this paper
• Clinical development of gene therapy: results and lessons from recent successes

  2016cited by this paper
• The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur

  2015cited by this paper
• Two-stage therapeutic utility of ectopically formed bone tissue in skeletal muscle induced by adeno-associated virus containing bone morphogenetic protein-4 gene

  2015cited by this paper
• Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

  2014cited by this paper
• Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

  2014cited by this paper
• Manual isolation of adipose-derived stem cells from human lipoaspirates.

  2013cited by this paper
• A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype

  2013cited by this paper
• Gene therapy for bone regeneration.

  2013cited by this paper
• Adeno‐associated virus‐coated allografts: a novel approach for cranioplasty

  2012cited by this paper
• Cell-loaded gellan gum-based hydrogels for nucleus pulposus regeneration

  2012cited by this paper
• Gene delivery to bone.

  2012cited by this paper
• Orthopaedic gene therapy using recombinant adeno-associated virus vectors.

  2011cited by this paper
• "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair.

  2011cited by this paper
• In vitro evaluation of a double-stranded self-complementary adeno-associated virus type2 vector in bone marrow stromal cells for bone healing

  2011cited by this paper
• High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy

  2010cited by this paper
• Measurement of insertional mutagenesis by retroviral and lentiviral vectors.

  2008cited by this paper
• Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.

  2008cited by this paper
• Adeno-associated viral vector transduction of human mesenchymal stem cells.

  2007cited by this paper
• Virus-based gene therapy strategies for bone regeneration.

  2007cited by this paper
• Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?

  2007cited by this paper
• Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review.

  2007cited by this paper
• In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells

  2007cited by this paper
• Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats.

  2007cited by this paper
• Viral vectors for gene delivery in tissue engineering.

  2006cited by this paper
• Gene Transfer into Rat Mesenchymal Stem Cells: A Comparative Study of Viral and Nonviral Vectors

  2006cited by this paper
• Different Osteogenic Potentials of Recombinant Human BMP-6 Adeno-Associated Virus and Adenovirus in Two Rat Strains

  2006cited by this paper
• Bone tissue engineering by gene delivery.

  2006cited by this paper
• In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models

  2006cited by this paper
• Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo.

  2005cited by this paper
• Biological effects of rAAV-caAlk2 coating on structural allograft healing.

  2005cited by this paper
• Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo.

  2005cited by this paper
• Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy

  2005cited by this paper
• An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.

  2004cited by this paper
• Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells

  2004cited by this paper
• Effect of hydroxyurea and etoposide on transduction of human bone marrow mesenchymal stem and progenitor cell by adeno-associated virus vectors.

  2004cited by this paper
• Combination of adeno-associated virus and adenovirus vectors expressing bone morphogenetic protein-2 produces enhanced osteogenic activity in immunocompetent rats.

  2004cited by this paper
• Intracellular Viral Processing, Not Single-Stranded DNA Accumulation, Is Crucial for Recombinant Adeno-Associated Virus Transduction

  2004cited by this paper
• Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors

  2003cited by this paper
• Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation.

  2003cited by this paper
• Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters

  2001cited by this paper
• Impaired Intracellular Trafficking of Adeno-Associated Virus Type 2 Vectors Limits Efficient Transduction of Murine Fibroblasts

  2000cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper

• Application Strategies of Bone Marrow Mesenchymal Stromal Cells in Bone-Related Diseases.

  2026cites this paper
• Regional Gene Therapy for Bone Tissue Engineering: A Current Concepts Review

  2025cites this paper
• Mesenchymal stem cells lineage and their role in disease development

  2024cites this paper
• Optimization of adeno-associated virus (AAV) gene delivery into human bone marrow stem cells (hBMSCs)

  2023cites this paper
• Adenovirus-Based Gene Therapy for Bone Regeneration: A Comparative Analysis of In Vivo and Ex Vivo BMP2 Gene Delivery

  2023cites this paper
• Delivery of Growth Factors to Enhance Bone Repair

  2023cites this paper
• Musculoskeletal tissue engineering: Regional gene therapy for bone repair.

  2021cites this paper
• Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy

  2021cites this paper
• Interactions between induced pluripotent stem cells and stem cell niche augment osteogenesis and bone regeneration

  2021cites this paper
• Gene Therapy for Bone Healing: Lessons Learned and New Approaches.

  2021cites this paper